Characterization of r132h mutation-specific idh1 antibody binding in brain tumors

Brain Pathology

Volumn 20, Issue 1, 2010, Pages 245-254

  Capper, David ^a   Weißert, Susanne ^a   Balss, Jörg ^b   Habel, Antje ^a   Meyer, Jochen ^b   Jäger, Diana ^a   Ackermann, Ulrike ^b   Tessmer, Claudia ^b   Korshunov, Andrey ^b   Zentgraf, Hanswalter ^b   Hartmann, Christian ^a,b   Von Deimling, Andreas ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Antibody; Glioma; IDH1; Immunohistochemistry; Isocitrate dehydrogenase; R132H

Indexed keywords

ENZYME ANTIBODY; ISOCITRATE DEHYDROGENASE 1 R132H MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER TISSUE; CELL INFILTRATION; CELL NUCLEUS; CHILD; CONTROLLED STUDY; CYTOPLASM; EMBRYO; EPENDYMOMA; FEMALE; GENE FREQUENCY; GENE LOCATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDULLOBLASTOMA; MENINGIOMA; MOUSE; NEURILEMOMA; NONHUMAN; OLIGODENDROGLIOMA; POINT MUTATION; PRESCHOOL CHILD; PROTEIN DETERMINATION; RAT; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; TUMOR CELL; WESTERN BLOTTING; WILD TYPE;

ADOLESCENT; ADULT; AGED; ANTIGEN-ANTIBODY REACTIONS; ASTROCYTOMA; BLOTTING, WESTERN; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CLONING, MOLECULAR; DNA, NEOPLASM; EPENDYMOMA; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; ISOCITRATE DEHYDROGENASE; MALE; MIDDLE AGED; MUTATION; PROTEIN BIOSYNTHESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 71549122009     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2009.00352.x     Document Type: Article

References (22)

1. Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A (2008) Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116 : 597 602.
2. Bleeker FE, Lamba S, Leenstra S, Troost D, Hulsebos T, Vandertop WP et al (2009) IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat 30 : 7 11.
3. Capper D, Zentgraf H, Balss J, Hartmann C, von Deimling A (2009) Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol 118 : 599.
4. Harlow E, Lane D (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory : New York.
5. Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A et al (2009) Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1010 diffuse gliomas. Acta Neuropathol 118 : 469 474.
6. Ichimura K, Pearson DM, Kocialkowski S, Backlund LM, Chan R, Jones DT, Collins VP (2009) IDH1 mutations are present in the majority of common adult gliomas but are rare in primary glioblastomas. Neuro Oncol 11 : 341 347.
7. Kang MR, Kim MS, Oh JE, Kim YR, Song SY, Seo SI et al (2009) Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int J Cancer 125 : 353 355.
8. Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256 : 495 497.
9. Korshunov A, Meyer J, Capper D, Christians A, Remke A, Witt H et al (2009) Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Acta Neuropathol 118 : 401 405.
10. Louis D, Ohgaki H, Wiestler O, Cavenee W (2007) World Health Organization classification of tumours of the central nervous system IARC : Lyon, France.
11. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K et al (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 361 : 1058 1066.
12. Meyer J, Pusch S, Balss J, Capper D, Mueller W, Christians A et al (2009) PCR and restriction endonuclease-based detection of IDH1 mutations. Brain Pathol Epub ahead of print DOI: 10.1111/j.1750-3639.2009.00327.x.
13. Narahara K, Kimura S, Kikkawa K, Takahashi Y, Wakita Y, Kasai R et al (1985) Probable assignment of soluble isocitrate dehydrogenase (IDH1) to 2q33.3. Hum Genet 71 : 37 40.
14. Nobusawa S, Watanabe T, Kleihues P, Ohgaki H (2009) IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res 15 : 6002 6007.
15. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321 : 1807 1812.
16. Sanson M, Marie Y, Paris S, Idbaih A, Laffaire J, Ducray F et al (2009) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 27 : 4150 4154.
17. Scherer H (1938) Structural development in gliomas. Am J Cancer 34 : 333 351.
18. Watanabe T, Nobusawa S, Kleihues P, Ohgaki H (2009) IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174 : 653 656.
19. Weller M, Felsberg J, Hartmann C, Berger H, Steinbach J, Schramm J et al 2009) Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma. A prospective translational study of the German Glioma Network. J Clin Oncol Epub ahead of print DOI: 10.1200/JCO.2009.23.0805.
20. Wick W, Stoffels M, Engel C, Hartmann C, Felsberg J, Stockhammer F et al NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide. J Clin Oncol (in press).
21. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360 : 765 773.
22. Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P et al (2009) Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324 : 261 265.